Sign In
Buy GILD
$125.05
+0.180 (+0.144%)
At Close: Jun 23, 2026
Gilead Sciences (GILD) Exceeds Market Returns: Some Facts to Consider
06:51pm, Thursday, 11'th Sep 2025
In the latest trading session, Gilead Sciences (GILD) closed at $117.86, marking a +2.26% move from the previous day.
Gilead Sciences, Inc. (GILD) Presents At Baird Global Healthcare Conference 2025 Transcript
01:38pm, Wednesday, 10'th Sep 2025
Gilead Sciences, Inc. (NASDAQ:GILD ) Baird Global Healthcare Conference 2025 September 10, 2025 11:25 AM EDT Company Participants Cindy Perettie - Executive Vice President of Kite Conference Call Part
Gilead Sciences, Inc. (GILD) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)
02:16pm, Tuesday, 09'th Sep 2025
Gilead Sciences, Inc. (NASDAQ:GILD ) Morgan Stanley 23rd Annual Global Healthcare Conference September 9, 2025 10:45 AM EDT Company Participants Daniel O'Day - Chairman & CEO Johanna Mercier - Chief C
FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced a partnership with the U.S. State Department and the United States President's Emergency Plan for AIDS Relief
US plans to bring Gilead HIV drug to market in high-burden HIV countries
02:13pm, Thursday, 04'th Sep 2025
The U.S. State Department announced a plan on Thursday to bring Gilead Sciences Inc's drug lenacapavir to market "at cost" in high-burden HIV countries in an effort to reach 2 million people over thre
Gilead Sciences, Inc. (GILD) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 Transcript
02:00pm, Thursday, 04'th Sep 2025
Gilead Sciences, Inc. (NASDAQ:GILD ) Wells Fargo 20th Annual Healthcare Conference 2025 September 4, 2025 11:00 AM EDT Company Participants Andrew Dickinson - Chief Financial Officer Conference Call P
Gilead Sciences Launches Choose U™ Campaign Spotlighting the Inspiring Experiences of People Living with HIV
08:30am, Thursday, 04'th Sep 2025
FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced the launch of Choose U™, a new campaign that spotlights the multifaceted experiences of people living with
Gilead Sciences, Inc. (GILD) Presents At Cantor Global Healthcare Conference 2025 Transcript
02:30pm, Wednesday, 03'rd Sep 2025
Gilead Sciences, Inc. (NASDAQ:GILD ) Cantor Global Healthcare Conference 2025 September 3, 2025 11:30 AM EDT Company Participants Dietmar Berger - Chief Medical Officer Conference Call Participants Ca
Global drugmakers rush to boost US presence as tariff threat looms
02:09pm, Wednesday, 03'rd Sep 2025
Global drugmakers are scrambling to shore up their U.S. manufacturing capacity and domestic inventory as the Trump administration weighs hefty tariffs on pharmaceutical imports into the country.
Gilead starts building manufacturing hub under $32 billion planned US investments
12:16pm, Wednesday, 03'rd Sep 2025
Gilead Sciences said on Wednesday it has started work on a new pharmaceutical development and manufacturing hub at its headquarters in Foster City, California, as part of its planned $32 billion inves
Gilead Sciences Breaks Ground on New Manufacturing Hub, a Cornerstone of Its U.S. Growth and Innovation Strategy
11:30am, Wednesday, 03'rd Sep 2025
FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences (Nasdaq: GILD) today celebrates the groundbreaking of its new Pharmaceutical Development and Manufacturing (PDM) Technical Development Center (NTD
Gilead Sciences: HIV Leadership Outshines Decline In COVID-19 Drug Sales
09:20am, Tuesday, 02'nd Sep 2025
Despite retail investors' cautious attitude toward Gilead Sciences, it once again beat analysts' expectations by a wide margin. In my estimation, Gilead's main star remains Biktarvy, which leaves comp
Here is What to Know Beyond Why Gilead Sciences, Inc. (GILD) is a Trending Stock
10:01am, Thursday, 28'th Aug 2025
Gilead (GILD) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
GILD Wins Approval for Twice-Yearly HIV Prevention Shot in the EU
10:41am, Tuesday, 26'th Aug 2025
Gilead secures EU approval for twice-yearly HIV prevention shot Yeytuo, backed by strong trial data and expanded market protection.
Grab These 4 Safe DJIA Dividend Bargains After Index Hits All-Time Highs
09:34am, Tuesday, 26'th Aug 2025
The Dow Jones Industrial Average (DJIA) is one of the oldest and most widely recognized stock market indices in the world.
